Gludapa Tablet 5 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.
MFDS item code 202200944 · Approved 2022.03.04
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be administered alone or in combination with other medications as an adjunct to dietary and exercise therapy. It is particularly applicable to patients with cardiovascular diseases or with cardiovascular risk factors. The treatment helps improve blood sugar control and manage the risk of cardiovascular events. This medication is effectively used for the treatment of type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients receiving dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in patients who have had allergic reactions to the active ingredient or additives of this medication. It should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those on dialysis. Caution should be exercised when using in patients with low fluid volume or impaired kidney function, and renal function and fluid status should be checked before use. This medication can lower blood pressure and may affect kidney function, so symptoms of hypotension or changes in kidney function should be monitored regularly. In patients with moderate or severe kidney impairment, the blood sugar control effect may be reduced, therefore use is not recommended. This medication may increase the risk of genital infections and urinary tract infections, so if any symptoms of infection arise, the healthcare provider should be informed immediately. There is a risk of hypoglycemia, so careful consideration of dosage adjustments is needed when used with insulin or sulfonylurea drugs due to the risk of hypoglycemia. If symptoms of dehydration or hypotension due to decreased fluid volume occur, the administration of this medication should be temporarily halted and the condition should be restored. Serious metabolic disorders such as diabetic ketoacidosis may occur; immediate treatment should be sought if related symptoms (nausea, vomiting, abdominal pain, difficulty breathing, etc.) appear. Elderly patients or those on diuretics have a higher risk of fluid volume loss and hypotension and require additional caution. Pregnant or breastfeeding women should avoid using this medication, and it should be discontinued if pregnancy is confirmed. The safety and efficacy in pediatric patients have not been established, so it is generally not used. There is no specific antidote for overdose, so appropriate treatment should be given based on symptoms, and medical attention should be sought if necessary. This medication does not affect the ability to drive or operate machinery, but caution is required due to the risk of hypoglycemia when taken with insulin or sulfonylurea.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated blood creatinine at the beginning of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral arterial occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempts, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, sensory loss, headache, nasopharyngitis, upper respiratory tract infection, edema, fever, sensation of foreign body, facial edema, facial pain, warmth, flu-like symptoms, chest pain, fatigue, discomfort in the chest, peripheral edema, generalized edema, hunger, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, excessive sweating eczema, coin eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, flank pain, fibromyalgia, discomfort in the limbs, muscle cramps, musculoskeletal discomfort, osteopenia, contusion, road traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, pelvic fracture, laceration, ligament rupture, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibial fracture, dental injury, dry eye, eye pain, retinal disorder, decreased vision, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, glaucoma, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice impairment, nasal bleeding, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, palpitations, anxiety disorder, enuresis, insomnia, fatty liver, gallbladder polyp, tinnitus, vaginal discharge, urinary retention, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased appetite, next syndrome, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorder, syncope, tremor, herpes simplex, edema, fever, sensation of foreign body, facial edema, facial pain, warmth, flu-like symptoms, chest pain, fatigue, discomfort in the chest, peripheral edema, generalized edema, hunger, vaginal discharge, itching, urticaria, cold sweat, joint pain, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It should also be kept away from extreme heat or cold, ideally stored at room temperature between 1 to 30 degrees Celsius.
Yellow round film-coated tablets
Bottle - 28 tablets/bottle, Box - 28 tablets/box[(7 tablets/Alu-Alu*4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.